MBF Bioscience designs quantitative microscope imaging systems for counting cells and quantifying the neuronal structure of the central nervous system at the cellular level. Microscopic analysis yields important information about the function and pathology of the nervous system, integral to the development of novel treatment strategies for brain injury and disease. MBF systems have aided in many important discoveries for both basic research and drug discovery in fields such as autism spectrum disorder, traumatic brain injury, Alzheimer’s, Parkinson, and Huntington’s diseases. In addition to neuroscience medical research, MBF products are used extensively in stem cell, lung, kidney, reproductive, cardiac, genetic, and toxicology research.

MBF Bioscience received its first SBIR grant in 1989. Since then, the company has grown to 39 employees today, and has generated over $100 million in revenues. As one of the most respected high-tech companies in Vermont, MBF has been able to recruit and retain employees locally and nationally by offering a stimulating work environment and paying well above the median income ranges for their region. MBF earned the distinction as one of the Best Places to Work in Vermont in 2007, 2009, and 2010. The award honors employers who strive to create better workplaces for their employees, in turn benefiting the state’s economy. In 2007, the United States Small Business Administration presented MBF president Jack Glaser with the Vermont Small Business Person of the Year award. They selected him for his outstanding leadership related to his company’s staying power, growth, sales, innovation, and community contributions.

As a member of the local economy, MBF supports many local charities, schools, and associations. In 2012, MBF received the Ben Blood award for continued support of the Chittenden Emergency Food Shelf. MBF employees give back to their communities through coaching, mentoring, tutoring and volunteering – all supported by the company.